We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

98 hedge funds and large institutions have $115M invested in VanEck Biotech ETF in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.61% less ownership

Funds ownership: 35.45% → 34.84% (-0.61%)

6% less funds holding

Funds holding: 104 → 98 (-6)

11% less capital invested

Capital invested by funds: $130M → $115M (-$14.3M)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

57% less call options, than puts

Call options by funds: $276K | Put options by funds: $644K

Holders
98
Holders Change
-6
Holders Change %
-5.77%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
25
Closed
16
Calls
$276K
Puts
$644K
Net Calls
-$368K
Net Calls Change
-$2.77M

Top Buyers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
+$7.19M
2
BFG
Bleakley Financial Group
New Jersey
+$2.83M
3
Bank of America
Bank of America
North Carolina
+$1.18M
4
Citadel Advisors
Citadel Advisors
Florida
+$840K
5
Citigroup
Citigroup
New York
+$816K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$6.8M
2
Wells Fargo
Wells Fargo
California
-$5.13M
3
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$3.11M
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$2.66M
5
MIM
Miller Investment Management
Pennsylvania
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wealthfront Advisers
26
Wealthfront Advisers
California
$911K -$195K -1,307 -18%
Cerity Partners
27
Cerity Partners
New York
$888K +$6.4K +43 +0.7%
ACA
28
Atlas Capital Advisors
Wyoming
$874K – – –
Citigroup
29
Citigroup
New York
$840K +$816K +5,482 New
CIBC Private Wealth Group
30
CIBC Private Wealth Group
Georgia
$760K – – –
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$758K -$106K -713 -13%
PSF
32
Pacific Sun Financial
California
$673K -$64K -430 -9%
JP Morgan Chase
33
JP Morgan Chase
New York
$658K -$453K -3,044 -41%
PPWM
34
Paragon Private Wealth Management
Kentucky
$635K +$617K +4,140 New
PNC Financial Services Group
35
PNC Financial Services Group
Pennsylvania
$613K – – –
NWA
36
Navis Wealth Advisors
New York
$610K – – –
AL
37
Aspiriant LLC
California
$571K -$76K -510 -12%
KAS
38
Kestra Advisory Services
Texas
$541K -$15.3K -103 -3%
Janney Montgomery Scott
39
Janney Montgomery Scott
Pennsylvania
$470K – – –
TRCT
40
Tower Research Capital (TRC)
New York
$459K -$177K -1,191 -28%
Jones Financial Companies
41
Jones Financial Companies
Missouri
$393K -$39.5K -265 -9%
FHA
42
Flagship Harbor Advisors
Massachusetts
$377K +$41.9K +281 +13%
EE
43
EWG Elevate
California
$363K +$353K +2,371 New
Wealth Enhancement Advisory Services
44
Wealth Enhancement Advisory Services
Minnesota
$358K – – –
WJWM
45
Williams Jones Wealth Management
New York
$337K – – –
PVI
46
Pine Valley Investments
New Jersey
$330K – – –
TYCC
47
Texas Yale Capital Corp
Florida
$320K – – –
Cetera Investment Advisers
48
Cetera Investment Advisers
Illinois
$311K -$158K -1,063 -34%
BFC
49
Blue Fin Capital
Rhode Island
$241K – – –
Northwestern Mutual Wealth Management
50
Northwestern Mutual Wealth Management
Wisconsin
$231K -$3.11M -20,853 -93%
1
2
3 4 5

BBH Hedge Fund Activity: Q2 2025 in Review

98 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2025, worth a combined $115M — down 11% from $130M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of BBH and 10 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 15 added.

The largest buyer was Raymond James Financial, adding an estimated $7.19M. The largest seller was Morgan Stanley, cutting an estimated $6.8M.

  • 98 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2025, down from 104 in Q1 2025.
  • Funds reported $115M of VanEck Biotech ETF stock for Q2 2025, down 11% quarter-over-quarter.
  • 10 funds opened new VanEck Biotech ETF positions in Q2 2025 and 16 closed out, a net change of -6 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2025 was Raymond James Financial, an estimated $7.19M added.
  • The largest VanEck Biotech ETF seller in Q2 2025 was Morgan Stanley, an estimated $6.8M sold.

Based on aggregated 13F filings for Q2 2025.